Award
NIH Reporter #11332504
Injectable Extended-Release Buprenorphine (XR-B) in a Correctional Setting: A Pilot Randomized Controlled Trial
Recipient
Rhode Island Hospital
Award Amount
$195,696.00
Ceiling
$195,696.00
Awarded
June 03, 2026
Identifier
11332504
NIH awarded a grant for a pilot randomized controlled trial to study injectable extended-release buprenorphine in correctional settings to prevent opioid overdose among incarcerated individuals.
Description
This NIH grant application proposes research on the effectiveness and implementation of injectable extended-release buprenorphine in correctional settings, aiming to prevent opioid overdose among incarcerated individuals. The project includes a randomized controlled trial and a process evaluation based on implementation science frameworks.